Precision targeting: AI's role in identifying disease drivers
06 May 2026
Target Identification
- Are we solving the right problem? How do we distinguish a computationally compelling target from a biologically meaningful one? Where is the field still falling short?
- Data Quality Problem: AI models are only as good as the biology they're trained on. How are teams addressing the biases embedded in existing omics, GWAS, and literature datasets? Are current benchmarks actually predictive of clinical success?
- Human-AI Collaboration: In your experience, where does AI augment the biologist's intuition — and where does it replace judgment it shouldn't? What does the ideal human-AI workflow look like for target prioritization?
- Translation Gap: How does AI inform target validation, tractability assessment, and indication selection—and what is the biggest remaining gap between target ID and a credentialed program?
- Competitive Landscape: With foundation model platforms like Noetik, Chai, and others entering this space, how do you see the target ID tooling market evolving? Will this capability become commoditized, or can durable differentiation be built?
Industry Expert
